Discover why Hims & Hers faces steep corrections amid GLP-1 headwinds and valuation concerns, despite promising FY2024 growth ...

Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...

Shares of Hims & Hers Health (NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence. The ...

The couple’s new perfume line, “Fridays by Tab & Chance,” is all about love, partnership, and smelling amazing—together.

Another Amber Alert was issued Wednesday for Azalea Strifler, a 15-year-old who went missing from Harnett County. The alert ...

Meghan Markle revealed this week that she, Prince Harry and children Archie, five, and Lilibet, three, were going by a new ...

Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...

During Clinton Elementary School’s monthly 4-H meeting, the members received an update on Delta Dawn, their adopted cow.

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ...

With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared ...

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended ...